Membrane‐Spanning Protein Genetic Polymorphisms Related to Methotrexate Therapeutic Outcomes in a Chinese Rheumatoid Arthritis Population

2019 ◽  
Vol 59 (11) ◽  
pp. 1471-1476
Author(s):  
Shuang Lv ◽  
Huizhen Fan ◽  
Hui Yang ◽  
Jing Huang ◽  
Jiang Li ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Genetic Polymorphisms ◽  
Rheumatoid Arthritis Population ◽  
Therapeutic Outcomes ◽  
Membrane Spanning

FRI0041 The Prediction of Nonadherence to Methotrexate at Six Months in a Rheumatoid Arthritis Population

2015 ◽  
Vol 74 (Suppl 2) ◽  
pp. 433.2-434 ◽  
Author(s):  
H.F. Hope ◽  
J. Anderson ◽  
A. Barton ◽  
L. Cordingley ◽  
K. Hyrich ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Rheumatoid Arthritis Population

scholarly journals A review of the methods used to define glucocorticoid exposure and risk attribution when investigating the risk of fracture in a rheumatoid arthritis population

Bone ◽  
2016 ◽  
Vol 90 ◽  
pp. 107-115 ◽  
Author(s):  
D.E. Robinson ◽  
E.M. Dennison ◽  
C. Cooper ◽  
T.P. van Staa ◽  
W.G. Dixon
Keyword(s):  
Rheumatoid Arthritis ◽  
Risk Of Fracture ◽  
Rheumatoid Arthritis Population ◽  
Risk Attribution

Pulmonary Manifestations of Rheumatoid Arthritis

2021 ◽  
Vol 36 (2) ◽  
pp. 97-103
Author(s):  
Keith J. Christensen ◽  
Mark A. Malesker ◽  
Nikhil Jagan ◽  
Douglas R Moore
Keyword(s):  
Rheumatoid Arthritis ◽  
Needle Biopsy ◽  
Pulmonary Toxicity ◽  
Pharmacy Practice ◽  
Pulmonary Function Testing ◽  
Therapeutic Outcomes ◽  
Pulmonary Manifestations ◽  
Lost To Follow Up ◽  
Function Testing

Objective To describe the case of an 88-year-old male with rheumatoid arthritis who developed pulmonary manifestations. Treatment for his RA previously included various biologics, while at the time of pulmonary consultation included meloxicam, methotrexate, and abatacept. Following chest scans, bronchoscopy, needle biopsy, pulmonary function testing, and a thoracentesis, the diagnosis of pleural effusion and nodules associated with rheumatoid arthritis was determined. The patient was recommended to follow-up with the pulmonologist but was lost to follow-up because of nonpulmonary and nonrheumatoid arthritis complications. Settings Ambulatory clinic pharmacy practice, Community pharmacy, Consultant pharmacy practice. Practice Considerations Drugs used to treat rheumatoid arthritis may produce pulmonary toxicity similar to what is seen with the disease itself. Drug therapy may require modification if identified as an offending agent causing pulmonary manifestations. If fibrosing interstitial lung disease develops, the addition of nintedanib may need to be considered. Conclusion In order for pharmacists to better assist providers and patients and improve therapeutic outcomes, it is important for pharmacists to understand that pulmonary manifestations are common in patients having rheumatoid arthritis as well as with drugs used to treat rheumatoid arthritis.

scholarly journals Diagnostic role of lncRNA GAS5 and its genetic polymorphisms rs2067079, rs6790 and rs17359906 in rheumatoid arthritis

2021 ◽  
Vol 15 (5) ◽  
Author(s):  
Azza Elamir ◽  
Soha Senara ◽  
Noha Abdelghaffar ◽  
Sylvana Gaber ◽  
Hassan El Sayed
Keyword(s):  
Rheumatoid Arthritis ◽  
Genetic Polymorphisms ◽  
Diagnostic Role ◽  
Lncrna Gas5

scholarly journals Association of the genetic polymorphisms in inhibiting and activating molecules of immune system with rheumatoid arthritis: A systematic review and meta-analysis

2021 ◽  
Vol 26 (1) ◽  
pp. 22
Author(s):  
Nima Rezaei ◽  
MohammadJavad Mousavi ◽  
MohammadReza Hooshangi Shayesteh ◽  
Sirous Jamalzehi ◽  
Reza Alimohammadi ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Systematic Review ◽  
Immune System ◽  
Genetic Polymorphisms ◽  
Meta Analysis

Genetic Analysis of Rheumatoid Arthritis: Population and Family Studies

Arthritis ◽  
1981 ◽  
pp. 225-233
Author(s):  
D. Brackertz ◽  
P. Wernet
Keyword(s):  
Rheumatoid Arthritis ◽  
Genetic Analysis ◽  
Family Studies ◽  
Rheumatoid Arthritis Population

Pulmonary Manifestations of Rheumatoid Arthritis

2021 ◽  
Vol 36 (2) ◽  
pp. 97-103
Author(s):  
Keith J. Christensen ◽  
Mark A. Malesker ◽  
Nikhil Jagan ◽  
Douglas R Moore
Keyword(s):  
Rheumatoid Arthritis ◽  
Needle Biopsy ◽  
Pulmonary Toxicity ◽  
Pharmacy Practice ◽  
Pulmonary Function Testing ◽  
Therapeutic Outcomes ◽  
Pulmonary Manifestations ◽  
Lost To Follow Up ◽  
Function Testing

OBJECTIVE: To describe the case of an 88-yearold male with rheumatoid arthritis who developed pulmonary manifestations. Treatment for his RA previously included various biologics, while at the time of pulmonary consultation included meloxicam, methotrexate, and abatacept. Following chest scans, bronchoscopy, needle biopsy, pulmonary function testing, and a thoracentesis, the diagnosis of pleural effusion and nodules associated with rheumatoid arthritis was determined. The patient was recommended to follow-up with the pulmonologist but was lost to follow-up because of nonpulmonary and nonrheumatoid arthritis complications.<BR/> SETTINGS: Ambulatory clinic pharmacy practice, Community pharmacy, Consultant pharmacy practice.<BR/> PRACTICE CONSIDERATIONS: Drugs used to treat rheumatoid arthritis may produce pulmonary toxicity similar to what is seen with the disease itself. Drug therapy may require modification if identified as an offending agent causing pulmonary manifestations. If fibrosing interstitial lung disease develops, the addition of nintedanib may need to be considered.<BR/> CONCLUSION: In order for pharmacists to better assist providers and patients and improve therapeutic outcomes, it is important for pharmacists to understand that pulmonary manifestations are common in patients having rheumatoid arthritis as well as with drugs used to treat rheumatoid arthritis.

scholarly journals Significant Burden of Undiagnosed Emphysema in a Rheumatoid Arthritis Population

2020 ◽  
Author(s):  
A.J. Esposito ◽  
J. Sparks ◽  
R. Gill ◽  
H. Hatabu ◽  
E. Schmidlin ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Rheumatoid Arthritis Population ◽  
Significant Burden
Sign in / Sign up

Export Citation Format

Share Document